# US 2025/0155447 A1 · Methods and systems for processing polymeric analytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0155447 A1
- Document ID: US20250155447A1
- Status: Published application
- Kind: A1
- Application number: 18/907,854
- Filed: 2024-10-07
- Published: 2025-05-15
- Earliest claimed: 2022-04-08
- Assignees: Glyphic Biotechnologies, Inc.
- Applicants: Glyphic Biotechnologies, Inc.
- Inventors: David DODD; YashoNandini SINGH; Daniel Masao Estandian; Andrew John PRICE; Asmamaw WASSIE; Boyang HUA; Jai PRAKASH; Joshua Young Cynming YANG
- Web page: https://patentgrep.com/patent/US20250155447A1

## CPC

- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- G01N 33/6818: {Sequencing of polypeptides}
- G01N 33/54333: {Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction}
- G01N 33/6824: {involving N-terminal degradation, e.g. Edman degradation}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 2333/9015: Ligases (6)
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Novel approaches for processing polymeric analytes, such as biopolymers, are provided herein. A method for processing a polymeric analyte may comprise coupling a monomer of the polymeric analyte to a capture moiety, cleaving the monomer from the polymeric analyte, and analyzing the cleaved monomer, e.g., using a binding agent. The methods described herein may employ the use of activating agents.

## Claims

### Claim at position 1

1-99. (canceled)

### Claim 100

A method for sequencing a peptide comprising a plurality of amino acids, comprising:
(a) providing said peptide and a linker, wherein said linker is coupled to a linking nucleic acid molecule;
(b) coupling said linker to an amino acid of said plurality of amino acids;
(c) coupling said linking nucleic acid molecule to an oligonucleotide capture moiety;
(d) cleaving said amino acid from said peptide, thereby yielding a cleaved amino acid coupled to said oligonucleotide capture moiety;
(e) contacting said cleaved amino acid with a binding agent, wherein said binding agent comprises a detectable label; and
(f) detecting said detectable label, thereby identifying said amino acid.

### Claim 101 (depends on 100)

The method of claim 100, wherein said linker comprises an amino acid-reactive moiety.

### Claim 102 (depends on 100)

The method of claim 100, wherein said oligonucleotide capture moiety is coupled to a substrate.

### Claim 103 (depends on 102)

The method of claim 102, wherein said peptide is coupled to said substrate.

### Claim 104 (depends on 102)

The method of claim 102, wherein said substrate comprises a bead, a flow cell, a glass surface, or a silicon surface.

### Claim 105 (depends on 100)

The method of claim 100, wherein said detectable label is a fluorophore, radioisotope, mass tag, or chromogenic enzyme.

### Claim 106 (depends on 105)

The method of claim 105, wherein said detectable label comprises a fluorophore and wherein said detecting comprises imaging.

### Claim 107 (depends on 106)

The method of claim 106, wherein said imaging comprises super resolution microscopy.

### Claim 108 (depends on 100)

The method of claim 100, wherein said binding agent comprises an antibody, antibody fragment, aptamer, scFv, nanobody, anticalin, tRNA-acyl synthetase, peptide, peptide mimetic, a polysaccharide, or derivative thereof.

### Claim 109 (depends on 100)

The method of claim 100, wherein (c) comprises providing a plurality of binding agents, where said plurality of binding agents have specificity to different amino acids or derivatives thereof.

### Claim 110 (depends on 100)

The method of claim 100, further comprising, repeating (a)-(e).

### Claim 111 (depends on 100)

The method of claim 100, wherein said linking nucleic acid molecule or said oligonucleotide capture moiety comprises a barcode sequence.

### Claim 112 (depends on 110)

The method of claim 110, wherein said barcode sequence comprises temporal information.

### Claim 113 (depends on 112)

The method of claim 112, wherein said temporal information comprises a cycle number.

### Claim 114 (depends on 100)

The method of claim 100, wherein said binding agent comprises a cycle barcode that indicates a round or iteration in which said binding agent is provided.

### Claim 115 (depends on 100)

The method of claim 100, wherein said plurality of amino acids comprises a non-naturally occurring modification.

### Claim 116 (depends on 100)

The method of claim 100, wherein said amino acid is a terminal amino acid.

### Claim 117 (depends on 100)

The method of claim 100, wherein said oligonucleotide capture moiety comprises a polynucleotide analog.

### Claim 118 (depends on 117)

The method of claim 117, wherein said oligonucleotide capture moiety comprises a DNA molecule with a pseudo-complementary base, a bridged nucleic acid (BNA), a xenonucleic acid (XNA), a locked nucleic acid (LNA), a peptide nucleic acid (PNA), a gamma-PNA molecule, a morpholino, or a combination thereof.

### Claim 119 (depends on 100)

The method of claim 100, wherein said linking nucleic acid molecule or said oligonucleotide capture moiety comprises a unique molecular identifier (UMI).
